MiniMed (MMED) Receivables (2025 - 2026)
MiniMed (MMED) posted Receivables of $655.0 million for Q2 2026, little changed on a QoQ basis from $653.0 million in Q1 2026, and up 14.91% year-over-year from $570.0 million in Q2 2025.
MiniMed (MMED) Receivables (2025 - 2026) Analysis & Trends
MiniMed's Receivables history runs 2 years deep, the most recent figure standing at $655.0 million for Q2 2026.
- Quarterly Receivables rose 14.91% year-over-year to $655.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $655.0 million (up 14.91% YoY) and the FY2026 annual result came in at $655.0 million, up 14.91% from the prior year.
- Receivables was $655.0 million for Q2 2026 at MiniMed, roughly flat from $653.0 million in the prior quarter.
- Across five years, Receivables topped out at $655.0 million in Q2 2026 and bottomed at $570.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.28 Bn | 24.97 Bn | 662.02 Mn | 627.77 Mn |
| 2 | BrightSpring Health Services | 14.62 Bn | 13.72 Bn | 482.22 Mn | 1.17 Bn |
| 3 | Healthequity | 8.35 Bn | 8.08 Bn | 256.31 Mn | 122.00 Mn |
| 4 | Hinge Health | 5.98 Bn | 5.67 Bn | 154.23 Mn | 166.20 Mn |
| 5 | 10x Genomics | 5.88 Bn | 5.34 Bn | 106.18 Mn | 20.90 Mn |
| 6 | MiniMed | 4.50 Bn | 4.20 Bn | 480.00 Mn | 655.00 Mn |
| 7 | Waystar Holding | 4.47 Bn | 4.41 Bn | 216.84 Mn | 172.53 Mn |
| 8 | Doximity | 3.96 Bn | 3.21 Bn | 125.97 Mn | 146.98 Mn |
| 9 | Privia Health | 3.13 Bn | 2.71 Bn | - | 513.68 Mn |
| 10 | Omnicell | 1.89 Bn | 1.65 Bn | 140.36 Mn | 281.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 24, 2026 | 655.00 Mn |
| Jan 23, 2026 | 653.00 Mn |
| Apr 25, 2025 | 570.00 Mn |